These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 3349478

  • 1. Reversal of resistance to vincristine in P388 leukemia by various polycyclic clinical drugs, with a special emphasis on quinacrine.
    Inaba M, Maruyama E.
    Cancer Res; 1988 Apr 15; 48(8):2064-7. PubMed ID: 3349478
    [Abstract] [Full Text] [Related]

  • 2. Enhanced therapeutic effects on the multi-drug resistant human leukemia cells in vitro and xenograft in mice using the stealthy liposomal vincristine plus quinacrine.
    Liang GW, Lu WL, Wu JW, Zhao JH, Hong HY, Long C, Li T, Zhang YT, Zhang H, Wang JC, Zhang X, Zhang Q.
    Fundam Clin Pharmacol; 2008 Aug 15; 22(4):429-37. PubMed ID: 18705753
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [The effect of finoptin on doxorubicin accumulation in leukemia P-388 cells with induced resistance to the combination of finoptin and doxorubicin].
    Moroz LV, Donenko FV, Borovkova NB, Sitdikova SM, Kabieva AO.
    Biull Eksp Biol Med; 1990 Mar 15; 109(3):290-2. PubMed ID: 2364157
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Non-antitumor vinca alkaloids reverse multidrug resistance in P388 leukemia cells in vitro.
    Inaba M, Nagashima K.
    Jpn J Cancer Res; 1986 Feb 15; 77(2):197-204. PubMed ID: 3082832
    [Abstract] [Full Text] [Related]

  • 11. Effects of quinidine and related compounds on cytotoxicity and cellular accumulation of vincristine and adriamycin in drug-resistant tumor cells.
    Tsuruo T, Iida H, Kitatani Y, Yokota K, Tsukagoshi S, Sakurai Y.
    Cancer Res; 1984 Oct 15; 44(10):4303-7. PubMed ID: 6467192
    [Abstract] [Full Text] [Related]

  • 12. Combination vincristine and VP-16-213: evaluation of drug sequence.
    Jackson DV, Long TR, Rice DG, Morgan TM.
    Cancer Biochem Biophys; 1986 Oct 15; 8(4):265-75. PubMed ID: 3802048
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Overcoming drug resistance in cancer cells with synthetic isoprenoids.
    Yamaguchi T, Nakagawa M, Shiraishi N, Yoshida T, Kiyosue T, Arita M, Akiyama S, Kuwano M.
    J Natl Cancer Inst; 1986 May 15; 76(5):947-53. PubMed ID: 3457980
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Antitumor activity of idarubicin, a derivative of daunorubicin, against drug sensitive and resistant P388 leukemia.
    Tsuruo T, Oh-Hara T, Sudo Y, Naito M.
    Anticancer Res; 1993 May 15; 13(2):357-61. PubMed ID: 8517647
    [Abstract] [Full Text] [Related]

  • 20. Drug resistance studies on intraspecific hybridomas.
    Pályi I, Turi G, Szikla K, Dallmann L.
    Arch Geschwulstforsch; 1981 May 15; 51(1):119-24. PubMed ID: 7259434
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.